Form4insider filings, from the source

Company · CIK 0001637715 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

OnKure Therapeutics, Inc. · OKUR

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $1,157 · 2net −$1,157
$10k$10k$100k$100k$1M$1MbuyssalesJun 28Jul 13Jul 28Aug 13Aug 28Sep 13Sep 28

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 21, 2026 SForm 4 →Sep 23, 4:54 pm EDTNicholas A SaccomanoPresident and CEO, Director87$2.97$25911,160−0.77%
Sep 21, 2026 SForm 4 →Sep 23, 4:52 pm EDTJason A. LeveroneChief Financial Officer302$2.97$89818,500−1.61%

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Aug 7, 2026 AForm 4 →Aug 11, 4:43 pm EDTEdward T MathersDirector22,350——22,350—
Aug 7, 2026 AForm 4 →Aug 11, 4:40 pm EDTLiam RatcliffeDirector22,350——22,350—
Aug 7, 2026 AForm 4 →Aug 11, 4:39 pm EDTAndrew John PhillipsDirector22,350——22,350—
Aug 7, 2026 ADForm 4 →Aug 11, 4:39 pm EDTIsaac MankeDirector330,600——15,300— amended
Aug 7, 2026 AForm 4 →Aug 11, 4:37 pm EDTValerie Malyvanh JansenDirector22,350——22,350—
Aug 7, 2026 AForm 4 →Aug 11, 4:36 pm EDTMichael G GreyDirector22,350——22,350—
Aug 7, 2026 AForm 4 →Aug 11, 4:31 pm EDTR Michael CarruthersDirector22,350——22,350—
Aug 7, 2026 ADForm 4 →Aug 11, 4:27 pm EDTNicholas A SaccomanoPresident and CEO, Director1,292,846——542,232—
Aug 7, 2026 ADForm 4 →Aug 11, 4:26 pm EDTJason A. LeveroneChief Financial Officer333,428——130,611—
Aug 7, 2026 ADForm 4 →Aug 11, 4:25 pm EDTDylan HartleyChief Scientific Officer325,206——137,603—
Aug 7, 2026 ADForm 4 →Aug 11, 4:23 pm EDTSamuel AgrestaChief Medical Officer349,968——131,396—